Gene Query: GCFC2

Dataset Description Geneva Score
HNRNPM-regulated splicing dependencies in prostate cancer 15.79
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 15.79
Oncogenic MYC induces a dependency on the spliceosome in human cancer 14.59
IDH3a KO RNA-seq 12.22
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 12.19
ARID1A regulates condensin II distribution and chromosomal partition 12.19
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 11.65
LNCaP treated with iBET 11.57
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 11.53
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 11.39
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 10.35
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 10.35
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 10.06
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 9.65
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 9.65
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 9.42
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 9.23
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 8.6
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 8.34
Human cell line and subcutaneous tumor 8.18
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 7.95
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 7.64
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 7.64
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 7.46
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 7.25
RNA-seq of MDA-MB-231 cells with TET1 knockout 7.03
AR-independent prostate cancer is sustained through FGF signaling 6.93
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 6.81
Global Mapping of Human RNA-RNA Interactions 6.78
Global transcriptome analysis of HAP1 cells 6.5
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 6.43
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 6.4
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 6.39
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 6.2
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 6.2
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 6.14
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 5.94
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 5.93
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 5.87
RNAseq Analysis in glioblastoma cells treated with Mepazine 5.74
ChIP-seq and RNA-seq from human lymphoma cell lines 5.62
RNA-seq data from human lymphoma cell lines 5.62
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 5.55
Developmental stage specific chromosome architecture in human erythroid cells 5.55
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 5.5
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 5.44
Knockdown of ADNP in HCT116 colon cancer cells 5.33
R430: A potent inbibitor of DNA and RNA viruses 4.85
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 4.64
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 4.61
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 4.59
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 4.57
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 4.5
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 4.5
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 4.49
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 4.47
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 4.45
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 4.45
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 4.43
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 4.42
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 4.38
Identification of Nrf2 regulated genes by RNA sequencing 4.35
Nrf2 regulated genes in A549 cells 4.35
The cohesin complex prevents Myc-induced replication stress 4.31
RNA-Seq with and without RNase treatment in PCa cell lines 4.24
3’ Uridylation Expands miRNA Target Repertoire 4.16
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 4.15
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 4.11
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 4.07
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.05
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 4.05
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 4.02
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 3.99
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 3.99
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 3.96
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 3.96
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 3.94
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 3.92
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 3.91
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 3.91
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 3.91
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 3.88
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 3.87
Effect of from Human Umbilical Vein Endothelial Cells 3.85
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 3.84
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 3.83
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 3.81
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 3.81
Transcriptome-wide identification of CELF2 functional targets in T cells 3.78
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 3.77
Androgen Receptor-regulated genes in prostate cancer cells 3.77
Identification of long noncoding RNAs regulated by p53 3.76
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 3.74
Mapping interactions for the TNIP2 hub protein 3.71
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 3.67
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 3.63
RNA-seq of tumor cells following angiopellosis extravasation 3.62
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 3.61
RNA-seq analysis to identify the genes regulated by p53-SET interplay 3.58
Hijacking of stress response machinery by oncogenes in acute leukaemia 3.56
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 3.56
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 3.54
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 3.53
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 3.53
Control of prostate tumour growth by the long non-coding RNA GHSROS 3.5
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 3.44
Single-nucleotide-resolution mapping of HBV promoters using CAGE 3.43
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 3.42
Tracking distinct RNA populations using efficient and reversible covalent chemistry 3.37
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 3.37
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 3.37
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 3.37
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 3.36
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 3.36
Role for citron kinase in prostate cancer growth 3.34
Genome-wide discovery of human splicing branchpoints 3.33
TCF7L1 knockdown in pancreatic cancer 3.33
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 3.32
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 3.32
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 3.31
RNA-seq of RKO cells with cTAZ KO or putback 3.3
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 3.28
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.26
Loss of CREBBP results in gene expression repression in lymphoma cells 3.26
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 3.23
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 3.23
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 3.22
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 3.19
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 3.16
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 3.12
O-glcnAc reprograms cellular energetics 3.12
The landscape of alternative splicing in aggressive prostate cancers 3.11
N6-methyladenine DNA Modification in Glioblastoma 3.1
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 3.1
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 3.09
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 3.08
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 3.08
RNA sequencing of human mammary epithelial cells 3.06
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 3.05
Transcriptomic analysis of LSD1 3.04
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 3.04
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 3.03
CROP-Seq in Primary Human T Cells 3.03
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 3.03
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 3.02
Effect of PBK knockdown on C4-2 cell transcriptome 3.02
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 3.01
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.0
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 2.99
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 2.97
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.94
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 2.94
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 2.93
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 2.92
MYCL and EP400 are required for Max and MCPyV mediated gene activation 2.92
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 2.9
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 2.87
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 2.87
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 2.87
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 2.87
DART-seq: an antibody-free method for global m6A detection 2.84
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 2.83
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 2.8
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.79
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.79
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 2.76
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 2.76
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 2.76
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 2.75
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 2.75
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 2.74
Transciptomic profiling of human fetal lung samples 2.74
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 2.74
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 2.73
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 2.72
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 2.72
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 2.72
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 2.71
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 2.7
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.7
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 2.67
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 2.67
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 2.65
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 2.64
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 2.64
Identification of HOXB13 target genes responsive to BET inhibitors 2.63
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 2.62
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 2.62
The contribution of Alu exons to the human proteome 2.62
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 2.61
RNA-sequencing of human liver tissue 2.61
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 2.61
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 2.59
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 2.59
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.59
Gene expression in PANC1 cells treated with Rakicidin 2.58
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 2.58
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 2.58
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 2.58
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 2.57
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 2.57
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 2.56
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 2.56
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 2.56
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 2.56
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 2.55
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 2.55
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 2.54
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 2.53
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.51
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 2.51
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 2.51
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 2.5
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 2.49
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 2.49
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.48
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.48
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 2.46
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 2.45
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.43
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.43
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 2.42
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 2.41
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 2.41
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 2.41
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 2.4
Integrin signaling regulates YAP/TAZ to control skin homeostasis 2.4
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 2.4
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 2.4
The pause-initiation limit restricts transcription activation in human cells 2.39
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.39
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.39
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 2.39
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 2.38
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 2.38
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 2.38
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 2.38
Single-cell analysis of human kidney organoids 2.38
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 2.35
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 2.33
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 2.33
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 2.3
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 2.28
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 2.28
WRN knockout effects upon gene expression in SW48 and OVK18 2.28
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 2.28
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 2.28
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 2.28
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.27
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 2.27
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 2.26
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 2.25
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 2.25
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 2.23
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 2.23
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 2.23
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 2.22
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.2
Dtx3L and Androgen Signaling in Prostate Cancer 2.17
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.14
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.14
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 2.14
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 2.12
Transcriptome profiling of Normal and Cancerous Prostate Cells 2.12
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 2.11
Transcriptomic analysis of human tonsillar TFH subsets 2.11
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 2.11
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 2.11
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  2.11
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 2.07
Mutational landscape of splicing genes and functional consequences across 33 cancer types 2.07
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 2.03
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.03
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.02
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.02
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 2.01
RNA-seq of cells with TET1 knockout 2.01
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 2.0
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.99
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 1.98
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 1.98
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 1.97
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 1.95
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 1.95
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 1.93
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 1.93
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 1.92
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.92
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 1.92
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 1.9
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 1.9
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 1.89
FBXW7 modulates stress response by post-translational modification of HSF1 1.88
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 1.88
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.86
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.86
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.86
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 1.86
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.85
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 1.84
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 1.82
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 1.81
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 1.8
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 1.8
Effect of CHKA knockdown on C4-2 cell transcriptome 1.79
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 1.76
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.75
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 1.75
Gene expression signatures of innate lymphoid cells from human blood 1.73
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.73
The effect of Abl kinases on non-small cell carcinoma global transcriptome 1.72
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.71
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 1.71
KSDM1b Role in Ewing Sarcoma 1.69
RNA-seq analysis of control and Myc-induced U2OS cells 1.68
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 1.68
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 1.67
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.67
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.67
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 1.67
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 1.67
Role of COP1 on MAP kinase transcriptional output in melanoma 1.65
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 1.63
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 1.62
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 1.61
Modeling Human Cancer-induced Cachexia (Human) 1.6
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 1.6
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 1.58
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.56
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.56
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 1.5
Global analysis of alternative splicing regulated by RBM10 1.5
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.49
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.49
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 1.45
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 1.44
PRDM1 inhibits proliferation of human colon cancer organoids 1.43
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 1.42
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.4
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 1.4
IMP3 regulated gene expression in breast cancer cells 1.4
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 1.39
HEK293 TFAM Knockout Expression Study 1.39
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.38
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 1.37
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.35
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 1.31
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 1.31
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 1.3
RNA sequencing of T-ALL (COG study) 1.3
Analyses of T-ALL (COG study) 1.3
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 1.29
Characterization of human ILC2 subsets 1.29
Age-Related Gene Expression Changes in Prostate Cancer Patients 1.27
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 1.27
LIN28A Over-expression RNAseq 1.27
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.27
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.27
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 1.24
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.23
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 1.21
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 1.21
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 1.21
Transcriptome of EBV-infected gastric cancer cell lines 1.21
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 1.21
siRNA-mediated knockdown 1.21
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 1.2
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.18
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 1.17
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 1.17
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 1.15
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.15
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.15
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.14
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.14
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 1.11
SETBP1-WT and SETBP1-G870S epigenetic landscapes 1.11
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 1.11
Controlling for gene expression changes in transcription factor protein networks. 1.09
6mer seed toxicity in tumour suppressive microRNAs 1.08
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 1.07
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 1.06
Real-time observation of light-controlled transcription in living cells 1.05
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.04
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.04
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.03
Transcriptional landscape changes during human embryonic stem cell derivation 1.01
Transposon-based construction of strand-specific RNA-seq libraries 1.0
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 0.99
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.99
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 0.95
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 0.94
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.92
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.92
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.9
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.9
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 0.89
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 0.89
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.88
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.88
Oncogenic roles of ARID5B in T-ALL 0.86
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.86
Lysine benzoylation is a novel histone mark [RNA-seq] 0.83
Lysine benzoylation is a novel histone mark 0.83
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.82
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.82
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.8
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 0.8
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.79
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.76
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.76
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.76
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.76
Functional significance of the HIV-1 Tat signature amino acid residues 0.76
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.71
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.7
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.7
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.69
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 0.69
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.69
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 0.67
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 0.64
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 0.64
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 0.64
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.64
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 0.62
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.62
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 0.6
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.59
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.59
SRSF1 role in cellular gene expression and splicing 0.58
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 0.57
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.56
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.54
Transcriptome-wide response to synthetic chromatin protein PcTF 0.54
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.5
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.5
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.5
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 0.49
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.48
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.48
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 0.47
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 0.46
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.45
Systematic discovery of endogenous human ribonucleoprotein complexes 0.44
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.44
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.43
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.43
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.43
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 0.43
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 0.43
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.43
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.41
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.4
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.39
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.39
0.36
Human Treg IFNg/IL-10 subpopulations 0.33
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 0.32
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.31
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.31
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.3
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.3
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.29
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.26
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.26
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 0.26
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.26
RNA-seq data 0.25
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.23
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.22
The transcriptome and chromatin accessbility landscape of mammalian germline 0.2
Measure transcript integrity using RNA-seq data 0.19
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.18
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.18
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.17
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.17
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.16
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 0.15
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.13
Gene expression changes due to PARP knockdown in human cells 0.12
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.11
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.11
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.1
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.1
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.09
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.08
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.07
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 0.07
Modulation of nonsense-mediated decay by rapamycin 0.07
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.06
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.06
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.06
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.06
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.05
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.05
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.03
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 0.03
CDK4/6 inhibitor resistance in prostate cancer 0.03
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation